drugset / Trial / NCT04204382

Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer

NCT04204382

Phase 4 Unknown 144 enrolled Shanxi Zhendong Pharmacy Co., Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

Oral mucositis (OM) is an acute side effect of radiotherapy for head and neck cancer (HNC). OM associated pain affects oral functions and nutrition of the patient that may result in discontinuity of treatment.The purpose of this clinical study is to evaluate the therapeutic effects of Compound Kushen Injection (CKI) on oral mucositis caused by radiotherapy of head and neck cancer.

Timeline

Start
2019-12-12
Primary completion
2022-09-30
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Compound Kushen Injection Unknown 20 ml Intravenous
Background Levofloxacin Small molecule 0.5 g Intravenous

Indications